It's interesting to see what other ASX listed companies in the med tech field are doing in the US. I follow 4D Medical that has great tech and Sam Hupert from Pro Medicus is on the advisory board. The market cap is $197M so clearly investors like their offer of the non-invasive, quantitative analysis of lung function. However you need to have the stomach to handle the $1.3M revenue and $10M negative cash flow in the latest 4C,or the $3M revenue and $31M negative cash flow for the year. With M7T at $156M market cap and with an EV of $130M we know there is no cap raising around the corner. Cash flow positive with hopefully more signings in the 2nd half along with the VHA program - curiously 4DX has a role as well in this program. What's my point - they will definitely be a time to invest in 4DX but it's not now. At 197M market cap with money flying out the door (4DX) I can sleep at night as a M7T investor.
- Forums
- ASX - By Stock
- M7T
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add M7T (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.8M |
Open | High | Low | Value | Volume |
54.0¢ | 54.5¢ | 54.0¢ | $249.1K | 460.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 50356 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 37663 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 45642 | 0.540 |
2 | 7600 | 0.530 |
4 | 53091 | 0.525 |
3 | 9461 | 0.520 |
3 | 21275 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 37663 | 3 |
0.550 | 23018 | 2 |
0.555 | 15353 | 2 |
0.560 | 900 | 1 |
0.570 | 20901 | 1 |
Last trade - 13.59pm 11/10/2024 (20 minute delay) ? |
Featured News
M7T (ASX) Chart |